Concomitant chemoradiotherapy with altered cisplatin regimen in management of locally advanced head and neck cancers

被引：0
|
作者：
Abdelmaqsoud, A. [1 ]
Mueller, A. H. [2 ]
Knips, M. [1 ]
Bank, P. [1 ]
机构：
[1] ISRH Poliklin Gera, Strahlentherapie, Gera, Germany
[2] SRH Poliklin Gera, HNO, Gera, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2020年 / 196卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P25-23-jD
引用
收藏
页码：S137 / S137
页数：1
相关论文
共 50 条
  • [31] CHEMORADIOTHERAPY FOR THE TREATMENT OF REGIONALLY ADVANCED HEAD AND NECK CANCERS
    AISNER, J
    JACOBS, M
    SINABALDI, V
    GRAY, W
    EISENBERGER, M
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 35 - 44
  • [32] Comparitive study of quality of life in locally advanced head and neck cancers with concurrent chemoradiotherpy with three weekly cisplatin versus weekly cisplatin regimen.
    Adavikolanu, Kesava Ramgopal
    Malik, Monica
    Lachi, Pavankumar
    Kothwal, Syedakram
    Deepajoseph, M.
    Syed, Fayaz Ahmed
    Pamidighantam, Suresh
    Jagannathraonaidu, K., V
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [33] Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
    Jacinto, Alexandre Arthur
    Batalha Filho, Eronides Salustiano
    Viana, Luciano de Souza
    De Marchi, Pedro
    Capuzzo, Renato de Castro
    Gama, Ricardo Ribeiro
    Boldrini Junior, Domingos
    Santos, Carlos Roberto
    Junqueira Pinto, Gustavo Dix
    Dias, Josiane Mourao
    Canton, Heloisa Pelisser
    Carvalho, Raiany
    Radicchi, Lucas Augusto
    Bentzen, Soren
    Zubizarreta, Eduardo
    Carvalho, Andre Lopes
    BMC CANCER, 2018, 18
  • [34] Feasibility of concomitant cisplatin with hypofractionated radiotherapy for locally advanced head and neck squamous cell carcinoma
    Alexandre Arthur Jacinto
    Eronides Salustiano Batalha Filho
    Luciano de Souza Viana
    Pedro De Marchi
    Renato de Castro Capuzzo
    Ricardo Ribeiro Gama
    Domingos Boldrini Junior
    Carlos Roberto Santos
    Gustavo Dix Junqueira Pinto
    Josiane Mourão Dias
    Heloisa Pelisser Canton
    Raiany Carvalho
    Lucas Augusto Radicchi
    Soren Bentzen
    Eduardo Zubizarreta
    Andre Lopes Carvalho
    BMC Cancer, 18
  • [35] LONG-TERM EXPERIENCE WITH CISPLATIN-BASED INDUCTION CHEMOTHERAPY AND CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK-CANCER (HNC)
    STUPP, R
    HARAF, D
    KOZLOFF, M
    MCEVILLY, J
    WEICHSELBAUM, R
    VOKES, E
    CLINICAL RESEARCH, 1993, 41 (03): : A647 - A647
  • [36] Concomitant chemoradiotherapy in advanced squamous cell carcinoma of the head and neck
    Karlsruher, J
    Samith, A
    Krause, H
    1ST WORLD CONGRESS ON HEAD AND NECK ONCOLOGY, 1998, : 933 - 936
  • [37] Concomitant boost chemoradiotherapy in locally advanced head and neck cancer: Treatment tolerance and acute side effects
    Majdaeen, Mehrsa
    Kazemian, Ali
    Babaei, Mohammad
    Haddad, Peiman
    Hashemi, Farnaz Amouzegar
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (01) : 24 - 28
  • [38] Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer
    Boguszewicz, Lukasz
    Bielen, Agata
    Ciszek, Mateusz
    Skorupa, Agnieszka
    Mrochem-Kwarciak, Jolanta
    Skladowski, Krzysztof
    Sokol, Maria
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
  • [39] Chemoradiotherapy with high-dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma
    Hughes, Ryan T.
    Porosnicu, Mercedes
    Levine, Beverly J.
    Lycan, Thomas W., Jr.
    Shenker, Rachel F.
    Frizzell, Bart A.
    Greven, Kathryn M.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2021, 65 (06) : 796 - 805
  • [40] A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
    Patil, Vijay Maruti
    Noronha, Vanita
    Joshi, Amit
    Agarwal, Jaiprakash
    Ghosh-Laskar, Sarbani
    Budrukkar, Ashwini
    Murthy, Vedang
    Gupta, Tejpal
    Mahimkar, Manoj
    Juvekar, Shashikant
    Arya, Supreeta
    Mahajan, Abhishek
    Agarwal, Archi
    Purandare, Nilendu
    Rangarajan, Venkatesh
    Balaji, Arun
    Chaudhari, Sameer Vasant
    Banavali, Shripad
    Kannan, Sadhana
    Bhattacharjee, Atanu
    D'Cruz, Anil K.
    Chaturvedi, Pankaj
    Pai, Prathamesh S.
    Chaukar, Devendra
    Pantvaidya, Gouri
    Nair, Deepa
    Nair, Sudhir
    Deshmukh, Anuja
    Thiagarajan, Shivakumar
    Mathrudev, Vijayalakshmi
    Manjrekar, Aparna
    Dhumal, Sachin
    Maske, Kamesh
    Bhelekar, Arti Sanjay
    Nawale, Kavita
    Chandrasekharan, Arun
    Pande, Nikhil
    Goel, Alok
    Talreja, Vikas
    Simha, Vijai
    Srinivas, Sujay
    Swami, Rohit
    Vallathol, Dilip Harindran
    Dsouza, Hollis
    Shrirangwar, Sameer
    Turkar, Siddharth
    Abraham, George
    Thanky, Aditi Harsh
    Patel, Usha
    Pandey, Manish Kumar
    CANCER, 2019, 125 (18) : 3184 - 3197
12345